ClinicalTrials.Veeva

Menu

Gingival Crevicular Fluid of Adiponectin and Resistin As Predictable Implement in Staging and Grading System of Periodontitis

A

Al-Azhar University

Status

Completed

Conditions

Periodontal Diseases
Obesity, Morbid

Treatments

Procedure: non-surgical full-mouth periodontal therapy without using adjunct disinfectants
Diagnostic Test: GCF level of adiponectin and resistin

Study type

Interventional

Funder types

Other

Identifiers

NCT06604013
Obesity and Periodontitis

Details and patient eligibility

About

The goal of this clinical trial is to evaluate the relationship between obesity and gingival crevicular fluid resistin and adiponectin in periodontitis patients as well as assess the effect of non-surgical periodontal therapy on their levels using ELISA in obese individuals. Researchers will compare different stages of periodontitis to see if degrees of inflammation and periodontal therapy related obesity

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • obese persons with Body Mass Index (BMI) more than 40 and suffering from periodontitis

Exclusion criteria

  • Patients receiving either antibiotics or non-steroidal anti- inflammatory at least 3 months prior to samples collection.
  • Patients subjected to previous periodontal therapy 6 months before sampling. Patients with systemic or local inflammatory conditions other than periodontal disease.
  • Neither lactating nor pregnant.

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

60 participants in 4 patient groups

mild periodontitis (first stage, grade B)
Active Comparator group
Description:
mild periodontitis (first stage, grade B) manifesting CAL ≥ 1-2 mm, in corporation with percentage of bone loss level divided by age was 0.25-1% very year. patients received non-surgical full-mouth periodontal therapy without using adjunct disinfectants.
Treatment:
Diagnostic Test: GCF level of adiponectin and resistin
Procedure: non-surgical full-mouth periodontal therapy without using adjunct disinfectants
moderate periodontitis (second stage, grade B)
Active Comparator group
Description:
moderate periodontitis (second stage, grade B) manifesting CAL ≥ 3-4mm in corporation with percentage of bone loss level divided by age was 0.25-1% very year. patients received non-surgical full-mouth periodontal therapy without using adjunct disinfectants.
Treatment:
Diagnostic Test: GCF level of adiponectin and resistin
Procedure: non-surgical full-mouth periodontal therapy without using adjunct disinfectants
severe periodontitis (third stage, grade B)
Active Comparator group
Description:
severe periodontitis (third stage, grade B) manifesting CAL ≥ 5mm , in corporation with BoP increased than (30%), percentage of bone loss level divided by age was 0.25-1% very year. patients received non-surgical full-mouth periodontal therapy without using adjunct disinfectants
Treatment:
Diagnostic Test: GCF level of adiponectin and resistin
Procedure: non-surgical full-mouth periodontal therapy without using adjunct disinfectants
very severe periodontitis (forth stage, grade C)
Active Comparator group
Description:
very severe periodontitis (forth stage, grade C) manifesting CAL ≥ 5mm in corporation of percentage of bone loss level divided by age more than 1% very year. patients received non-surgical full-mouth periodontal therapy without using adjunct disinfectants
Treatment:
Diagnostic Test: GCF level of adiponectin and resistin
Procedure: non-surgical full-mouth periodontal therapy without using adjunct disinfectants

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems